Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
Early Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06744816
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
Information Needs, Preferences, and Understanding Trial (INPUT): a Randomized, Controlled Trial of the Effects of a Screening Tool on Illness Understanding
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT06743308
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 45
- Registration Number
- NCT06736600
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 400
- Registration Number
- NCT06722846
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
Interactive Design of Patient-Specific Molds for Tissue Shaping
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-02
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 160
- Registration Number
- NCT06711965
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-29
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT06708949
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06698822
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
A Study of the ApricityCare Program for Early Detection and Management of Treatment-related Adverse Events in Patients With Metastatic Cancer
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 425
- Registration Number
- NCT06693687
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-11
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT06683755
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
NCI Cervical Cancer 'Last Mile' Initiative 'Self-collection for HPV Testing to Improve Cervical Cancer Prevention
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 500
- Registration Number
- NCT06676150
- Locations
- ๐บ๐ธ
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath